Perimenopause and Your Health Data: Understanding What's Changing and Why

Perimenopause isn't a single event. It's a years-long process, and the standard approach to testing often isn't enough to identify it. This article explains what is actually shifting inside your body during this transition, which biomarkers capture those shifts, and why the way you test matters as much as what you test.

30 August 2026 · 7 min read

What perimenopause actually is

Menopause is a single point in time: 12 consecutive months without a period. Perimenopause is the transition leading up to it. Under the STRAW+10 staging system, which defines reproductive ageing, the menopausal transition lasts approximately four to seven years, though for some women it can span up to a decade. In Singapore, the average age of natural menopause is 49, earlier than the Western average of 51, according to data from the Singapore Medical Journal. This means many women enter perimenopause in their early-to-mid 40s. Some begin in their late 30s.

What makes this phase distinctive isn't a straightforward hormonal decline. It's fluctuation. Oestrogen swings unpredictably; surging one month, dropping the next. Progesterone falls more steadily as ovulation becomes less reliable. FSH rises and dips erratically as the brain tries to stimulate ovaries that are responding less consistently.

Why it's so often missed

The core challenge is that perimenopause frequently does not look like perimenopause, neither to the woman experiencing it nor to her doctor.

Symptoms tend to be real but nonspecific. Sleep disruption, anxiety, brain fog, fatigue, joint pain, heart palpitations, heavier or irregular cycles, weight shifting to the midsection. Research by the IWHP at National University Hospital Singapore and NUS Medicine found that joint and muscle discomfort rather than hot flashes, was the most commonly reported menopausal symptom among 1,054 Singaporean women, affecting 32.9% of participants. Overall, 62.6% reported at least one moderate-to-severe symptom. This challenges the Western-centric assumptions in much of the available health content.

Each of these symptoms has multiple plausible explanations. Stress. Poor sleep. Work pressure. And in time-pressed primary care settings, they're often investigated one at a time rather than as a pattern.

Blood tests compound the problem. A woman can have a normal FSH reading one week and a perimenopausal one the next, because hormonal swings during this phase are that wide. A single snapshot captures what was happening on that particular morning. It doesn't capture the trend.

The result is that women are frequently told their results are normal when they do not feel normal. This is not because anyone is being careless, but because the standard approach, which tests once and compares the result to a reference range, was not designed for a transition defined by volatility.

What to track and what each marker actually tells you

If single readings can mislead, the answer is smarter testing — and tracking over time. Test every three to six months during active perimenopause. It's the trend across multiple readings that reveals the real picture.

The hormonal markers that matter most

Three markers form the core of perimenopause tracking:

FSH is a signal from the brain telling the ovaries to work. A rising trend over time is one of the earliest measurable signs of perimenopause.

Oestradiol, the main form of oestrogen, does not taper quietly; it swings, sometimes surging before dropping sharply.

Progesterone drops as ovulation becomes less regular, often earlier than oestradiol shifts. Low progesterone relative to oestrogen can drive sleep disruption, anxiety, and heavier periods.

Beyond these three, a few markers add useful context. LH reflects ovulation regularity. SHBG shows how much hormone is actually reaching your tissues. AMH indicates ovarian reserve and, unlike FSH, stays relatively stable across the menstrual cycle, which makes it a more reliable single-point reading.

Don't stop at reproductive hormones

Perimenopause does not only affect sex hormones; it destabilises connected systems, and the symptoms overlap almost entirely:

Thyroid function is more likely to shift during perimenopause. The prevalence of both overt and subclinical hypothyroidism is significantly elevated during the late menopausal transition, and the symptoms such as fatigue, mood changes, weight gain, sleep disturbances, mirror perimenopause almost exactly.

Iron is directly required for thyroid hormone production; it is a key component of the thyroid peroxidase (TPO) enzyme, which catalyses the synthesis of T4 and T3.

Vitamin D supports bone health and immune function, and commonly dips during this period.

These systems interact. Declining oestrogen affects thyroid sensitivity. Low iron impairs thyroid function. Low vitamin D accelerates bone loss. A single hormone panel won't show these connections; tracking them together over time will.

The metabolic dimension

This is the part most women aren't told about. Oestrogen protects insulin sensitivity, cardiovascular health, and bone density. As it fluctuates and declines, those protections weaken, often silently:

Total cholesterol and LDL levels increase in both perimenopausal and postmenopausal women alongside declining oestrogen.

Blood sugar regulation changes, even without dietary shifts. Oestrogen depletion is associated with worsening insulin resistance and increased risk of metabolic syndrome.

Lumbar spine bone mineral density loss accelerates markedly during the late perimenopause, with the rate of loss most rapid in Japanese and Chinese women.

Metabolic syndrome prevalence is significantly higher in perimenopausal women compared to premenopausal women (49.2% vs 35.7%), with elevated FSH correlating with higher waist circumference, blood pressure, and triglycerides. Tracking a lipid panel, HbA1c, and bone density during perimenopause creates a window to intervene early.

Symptoms alongside biomarkers

Numbers alone don't tell the full story. When your fatigue spikes in the same months your oestradiol drops, that's data. When your anxiety worsens as progesterone falls, that's signal, not noise.

When multiple health reports are uploaded over time rather than just one, a tool like Genie Health Locker can track and organise biomarker readings longitudinally. This makes trend observations and cross-marker correlations visible in a way that comparing individual printouts never will.

What this means for you

Perimenopause builds quietly across systems, over years. Understanding that this transition is measurable, and acting on it early, is the difference between navigating it and being caught off guard. Track what matters. Look at trends. Bring the full pattern to your doctor, not just a single symptom.

Read Next: The Blood Tests That Can Help Explain Fatigue

You might also like

Iron Deficiency in Women: Why Standard Panels Often Miss It

Fatigue, hair thinning, difficulty concentrating — these are classic signs of low iron. So why do so many women in Singapore receive a 'normal' report and no follow-up?

Women's Health · 20 April 2026 · 4 min read

PCOS and Blood Sugar: The Link Most Women in Singapore Don't Know About

Polycystic ovary syndrome affects roughly one in ten women — but its connection to insulin resistance and long-term metabolic risk rarely comes up in a standard GP consultation.

Women's Health · 8 March 2026 · 4 min read

Perimenopause in Your 40s: The Symptoms Most Singapore Women Don't Recognise

Perimenopause can begin a decade before menopause — yet most women reach their mid-40s with no framework for understanding what is happening to their bodies. Here is what to look for.

Women's Health · 20 December 2025 · 5 min read